Complications of rhBMP-2 utilization for posterolateral lumbar fusions requiring reoperation: A single practice, retrospective case series report

Spine Journal

Volumn 13, Issue 10, 2013, Pages 1244-1252

  Hoffmann, Martin F ^a,b   Jones, Clifford B ^c,d   Sietsema, Debra L ^c,d  

^a Grand Rapids Medical Education Partners   (United States)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c Michigan Orthopedic Center   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Bone morphogenetic protein; Complications; Nonunion; Seroma; Spinal arthrodesis

Indexed keywords

INFUSE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTHRODESIS; ARTICLE; BODY MASS; COMORBIDITY; DEBRIDEMENT; DECOMPRESSION SURGERY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG UTILIZATION; ENCHONDRAL OSSIFICATION; FEMALE; FOLLOW UP; FORAMINOTOMY; HUMAN; INFECTION; LAMINECTOMY; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; NERVE COMPRESSION; OBESITY; OFF LABEL DRUG USE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PRIVATE PRACTICE; PSEUDARTHROSIS; REOPERATION; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; SEROMA; SEX DIFFERENCE; SPINE FUSION;

BONE MORPHOGENETIC PROTEIN; COMPLICATIONS; NONUNION; SEROMA; SPINAL ARTHRODESIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE MORPHOGENETIC PROTEIN 2; FEMALE; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RECOMBINANT PROTEINS; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; SPINAL FUSION; TRANSFORMING GROWTH FACTOR BETA; YOUNG ADULT;

EID: 84887992796     PISSN: 15299430     EISSN: 18781632     Source Type: Journal    
DOI: 10.1016/j.spinee.2013.06.022     Document Type: Article

References (45)

1. S.D. Boden, J. Kang, H. Sandhu, and J.G. Heller Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies Spine 27 2002 2662 2673
2. S.D. Glassman, L.Y. Carreon, and M.J. Campbell The perioperative cost of Infuse bone graft in posterolateral lumbar spine fusion Spine J 8 2008 443 448
3. E.D. Arrington, W.J. Smith, and H.G. Chambers Complications of iliac crest bone graft harvesting Clin Orthop Relat Res 329 1996 300 309
4. J.M. Howard, S.D. Glassman, and L.Y. Carreon Posterior iliac crest pain after posterolateral fusion with or without iliac crest graft harvest Spine J 11 2011 534 537
5. E.J. Carragee, C.M. Bono, and G.J. Scuderi Pseudomorbidity in iliac crest bone graft harvesting: the rise of rhBMP-2 in short-segment posterior lumbar fusion Spine J 9 2009 873 879
6. R. Agarwal, K. Williams, C.A. Umscheid, and W.C. Welch Osteoinductive bone graft substitutes for lumbar fusion: a systematic review J Neurosurg Spine 11 2009 729 740
7. K.S. Cahill, J.H. Chi, A. Day, and E.B. Claus Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures J Am Med Assoc 302 2009 58 66
8. B.J. Williams, J.S. Smith, and K.M. Fu Does BMP increase the incidence of perioperative complications in spinal fusion? A comparison of 55,862 cases of spinal fusion with and without BMP Spine 36 2011 1685 1691
9. A.L. Shimer, F.C. Oner, and A.R. Vaccaro Spinal reconstruction and bone morphogenetic proteins: open questions Injury 40 3 Suppl 2009 S32 S38
10. K.H. Bridwell, P.A. Anderson, and S.D. Boden What's new in spine surgery J Bone Joint Surg Am 89 2007 1654 1663
11. T.E. Mroz, J.C. Wang, R. Hashimoto, and D.C. Norvell Complications related to osteobiologics use in spine surgery: a systematic review Spine 35 9 Suppl 2010 S86 S104
12. FDA. Public health notification. 2011. Available at: http://www.fda.gov/ MedicalDevices/Safety/AlertsandNotices/PublicHealthNotifications/UCM062000. Accessed March 5, 2011.
13. M.P. Garrett, U.K. Kakarla, R.W. Porter, and V.K. Sonntag Formation of painful seroma and edema after the use of recombinant human bone morphogenetic protein-2 in posterolateral lumbar spine fusions Neurosurgery 66 2010 1044 1049 discussion 9
14. L.B. Shields, G.H. Raque, and S.D. Glassman Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion Spine 31 2006 542 547
15. L.M. Tumialan, J. Pan, G.E. Rodts, and P.V. Mummaneni The safety and efficacy of anterior cervical discectomy and fusion with polyetheretherketone spacer and recombinant human bone morphogenetic protein-2: a review of 200 patients J Neurosurg Spine 8 2008 529 535
16. H.J. Meisel, M. Schnoring, and C. Hohaus Posterior lumbar interbody fusion using rhBMP-2 Eur Spine J 17 2008 1735 1744
17. B. McKay, and H.S. Sandhu Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications Spine 27 1 Suppl 2002 S66 S85
18. K. Singh, M. Dumonski, and T. Stanley Repeat use of human recombinant bone morphogenetic protein-2 for second level lumbar arthrodesis Spine 36 2011 192 196
19. S.D. Glassman, J. Howard, and J. Dimar II Complications with rhBMP-2 in posterolateral spine fusion: a consecutive series of one thousand thirty-seven cases Spine 36 2011 1849 1854
20. J.R. Dimar II, S.D. Glassman, and J.K. Burkus Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis J Bone Joint Surg Am 91 2009 1377 1386
21. B.K. Cypress Characteristics of physician visits for back symptoms: a national perspective Am J Public Health 73 1983 389 395
22. C.B. Johannes, T.K. Le, and X. Zhou The prevalence of chronic pain in United States adults: results of an internet-based survey J Pain 11 2010 1230 1239
23. R.A. Deyo Back surgery - who needs it? N Engl J Med 356 2007 2239 2243
24. J.A. Rihn, C. Gates, and S.D. Glassman The use of bone morphogenetic protein in lumbar spine surgery J Bone Joint Surg Am 90 2008 2014 2025
25. J.S. Fischgrund, M. Mackay, and H.N. Herkowitz 1997 Volvo Award winner in clinical studies. Degenerative lumbar spondylolisthesis with spinal stenosis: a prospective, randomized study comparing decompressive laminectomy and arthrodesis with and without spinal instrumentation Spine 22 1997 2807 2812
26. K.G. Abdullah, M.P. Steinmetz, E.C. Benzel, and T.E. Mroz The state of lumbar fusion extenders Spine 36 2011 1328 1334
27. S.D. Boden The ABCs of BMPs Orthop Nurs 24 2005 49 52 quiz 3-4
28. M.R. Urist, A. Mikulski, and A. Lietze Solubilized and insolubilized bone morphogenetic protein Proc Natl Acad Sci U S A 76 1979 1828 1832
29. E.J. Carragee, A.J. Ghanayem, and B.K. Weiner A challenge to integrity in spine publications: years of living dangerously with the promotion of bone growth factors Spine J 11 2011 463 468
30. A.P. Kant, W.J. Daum, S.M. Dean, and T. Uchida Evaluation of lumbar spine fusion. Plain radiographs versus direct surgical exploration and observation Spine 20 1995 2313 2317
31. F.B. Christensen, M. Laursen, and J. Gelineck Interobserver and intraobserver agreement of radiograph interpretation with and without pedicle screw implants: the need for a detailed classification system in posterolateral spinal fusion Spine 26 2001 538 543 discussion 43-44
32. K. Singh, J.D. Smucker, S. Gill, and S.D. Boden Use of recombinant human bone morphogenetic protein-2 as an adjunct in posterolateral lumbar spine fusion: a prospective CT-scan analysis at one and two years J Spinal Disord Tech 19 2006 416 423
33. K.B. Lee, C.E. Taghavi, and M.S. Hsu The efficacy of rhBMP-2 versus autograft for posterolateral lumbar spine fusion in elderly patients Eur Spine J 19 2010 924 930
34. J.D. Smucker, J.M. Rhee, and K. Singh Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine Spine 31 2006 2813 2819
35. K. Shahlaie, and K.D. Kim Occipitocervical fusion using recombinant human bone morphogenetic protein-2: adverse effects due to tissue swelling and seroma Spine 33 2008 2361 2366
36. L.Y. Carreon, S.D. Glassman, and D.C. Brock Adverse events in patients re-exposed to bone morphogenetic protein for spine surgery Spine 33 2008 391 393
37. M. Boakye, P.V. Mummaneni, and M. Garrett Anterior cervical discectomy and fusion involving a polyetheretherketone spacer and bone morphogenetic protein J Neurosurg Spine 2 2005 521 525
38. J.K. Burkus, M.F. Gornet, and S.D. Glassman Blood serum antibody analysis and long-term follow-up of patients treated with recombinant human bone morphogenetic protein-2 in the lumbar spine Spine 36 2011 2158 2167
39. R.W. Haid Jr., C.L. Branch Jr., J.T. Alexander, and J.K. Burkus Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages Spine J 4 2004 527 538 discussion 38-39
40. S.D. Glassman, J.M. Howard, A. Sweet, and L.Y. Carreon Complications and concerns with osteobiologics for spine fusion in clinical practice Spine 35 2010 1621 1628
41. A. Lubbeke, K.G. Moons, G. Garavaglia, and P. Hoffmeyer Outcomes of obese and nonobese patients undergoing revision total hip arthroplasty Arthritis Rheum 59 2008 738 745
42. M.A. Karunakar, S.N. Shah, and S. Jerabek Body mass index as a predictor of complications after operative treatment of acetabular fractures J Bone Joint Surg Am 87 2005 1498 1502
43. J.S. Smith, C.I. Shaffrey, and C.A. Sansur Rates of infection after spine surgery based on 108,419 procedures: a report from the Scoliosis Research Society Morbidity and Mortality Committee Spine 36 2011 556 563
44. Food and Drug Administration Executive Summary for P050036 Medtronic's AMPLIFY™ rhBMP-2 Matrix 2010 FDA Available at: http://www.fda.gov/ downloads/advisorycommittees/committeesmeetingmaterials/medicaldevices/ medicaldevicesadvisorycommittee/orthopaedicandrehabilitationdevicespanel/ ucm220079.pdf Accessed July 19, 2011
45. E.J. Carragee, E.L. Hurwitz, and B.K. Weiner A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned Spine J 11 2011 471 491